We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

share
  • facebook
  • twitter
  • linked in
  • google+
back top

Malfait Anne-Marie

Malfait Anne-Marie

Rush University Medical Center
Chicago, United States of America

Anne-Marie Malfait, MD PhD, is Professor of Medicine and the George W. Stuppy, MD, Chair of Arthritis at Rush University in Chicago IL. Anne-Marie received her MD degree in 1989 and her PhD in 1994, both from Ghent University in Belgium. Her early training was in rheumatology and basic research focused on cartilage metabolism in osteoarthritis. Her postdoctoral training at the Kennedy Institute of Rheumatology in London focused on the role of cytokines in inflammatory arthritis. In 2001, she joined the pharmaceutical industry, as part of a team for the development of disease-modifying osteoarthritis drugs (DMOADs). In 2009, Anne-Marie established a research group at Rush University, studying pain in osteoarthritis. Her group studies the relationship between joint damage and the neurobiological processes that underlie OA pain, with focus on animal models. The long-term goal is to develop more efficacious and safer analgesics and DMOADs. Anne-Marie has been an Associate Editor for Osteoarthritis and Cartilage and for Arthritis and Rheumatology since 2013. She currently serves on the Board of Directors of the Osteoarthritis Research Society International and is the chair of the Committee on Research of the American College of Rheumatology. She serves on the Board of Directors of the Rheumatology Research Foundation. She feels passionate about osteoarthritis and pain research. Anne-Marie serves as faculty on the US Bone and Joint Young Investigator Initiative, and is strongly committed to motivating young researchers to join the efforts to study this very common disease that is rapidly becoming one of the major unmet medical needs in the world.